
TXMD
Healthcare · Drug Manufacturers - Specialty & Generic · $21.6M market cap
$1.87+0.05 (+2.7%)Nov 13, 4:10 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 1 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | Time not confirmed | — | — | — |
| Aug 11, 2026 | Time not confirmed | — | 0.01 | — |
| May 18, 2026 | Time not confirmed | — | 0.00 | — |
| Mar 27, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 12, 2025 | Time not confirmed | — | 0.00 | — |
| Aug 12, 2025 | Time not confirmed | — | 0.05 | — |
| May 8, 2025 | Before the open | — | 0.02 | — |
| Mar 27, 2025 | Before the open | 0.04 | 0.02 | -45.3% |
| Nov 12, 2024 | Before the open | 0.04 | -0.05 | -232.0% |
| Aug 12, 2024 | After the close | 0.03 | -0.09 | -415.0% |
| May 10, 2024 | After the close | 0.03 | -0.08 | -355.3% |
| Mar 29, 2024 | After the close | -0.13 | -0.08 | +38.5% |
| Nov 14, 2023 | After the close | -0.05 | -0.32 | -540.0% |
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The…
| Aug 14, 2023 | Before the open | -0.07 | -0.24 | -242.9% |
| May 15, 2023 | After the close | 0.06 | -0.24 | -500.0% |
| Mar 27, 2023 | Before the open | -1.11 | 8.23 | +841.4% |
| Nov 14, 2022 | After the close | -2.04 | -3.13 | -53.4% |
| Aug 15, 2022 | Before the open | -3.04 | 12.39 | +507.6% |
| May 16, 2022 | After the close | -4.00 | -5.69 | -42.3% |
| Mar 10, 2022 | Before the open | -3.83 | -5.00 | -30.5% |
| Nov 11, 2021 | Before the open | -5.00 | -5.50 | -10.0% |
| Aug 4, 2021 | Before the open | -5.50 | -5.50 | 0.0% |
| May 6, 2021 | Before the open | -5.80 | -5.50 | +5.2% |
| Mar 2, 2021 | Before the open | -5.25 | -7.50 | -42.9% |
| Nov 9, 2020 | Before the open | -6.70 | -6.00 | +10.4% |
| Aug 6, 2020 | Before the open | -8.17 | -9.50 | -16.3% |
| May 6, 2020 | Before the open | -9.30 | -10.50 | -12.9% |
| Feb 20, 2020 | Before the open | -9.36 | -9.50 | -1.5% |
| Nov 6, 2019 | After the close | -9.50 | -6.50 | +31.6% |
| Aug 6, 2019 | After the close | -8.81 | -9.50 | -7.8% |
| May 6, 2019 | After the close | -8.49 | -8.00 | +5.8% |
| Feb 21, 2019 | After the close | -8.50 | -8.50 | 0.0% |
| Nov 7, 2018 | After the close | -9.58 | -8.00 | +16.5% |
| Jul 30, 2018 | Before the open | -6.17 | -7.50 | -21.6% |
| May 3, 2018 | After the close | -4.95 | -5.50 | -11.1% |
| Feb 20, 2018 | After the close | -4.25 | -5.00 | -17.6% |